RENAISSANCE Study: A Phase 2, Multicenter, Open Label Safety and Tolerability Study of SPN-817 in Adult Patients with Treatment Resistant Epilepsy

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Nicolo, John-Paul (Chief Investigator (CI))
  • Perucca, Piero (Chief Investigator (CI))
  • Reutens, David C. (Chief Investigator (CI))
  • Carney, Patrick (Chief Investigator (CI))
  • Somerville, Ernest Robertson (Chief Investigator (CI))
  • Wijayath, Manori (Chief Investigator (CI))
  • Wong, Toh (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date19/12/2218/12/24


  • Clinical Trials
  • Epilepsy